Literature DB >> 5556257

[Inhibition of prolactin secretion by ergocornine and 2-Br-alpha-ergocryptine: direct action on the hypophysis in culture].

J L Pasteels, A Danguy, M Frérotte, F Ectors.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5556257

Source DB:  PubMed          Journal:  Ann Endocrinol (Paris)        ISSN: 0003-4266            Impact factor:   2.478


× No keyword cloud information.
  20 in total

1.  Editorial: Bromocriptine--a changing scene.

Authors: 
Journal:  Br Med J       Date:  1975-12-20

2.  Stimulant properties of bromocriptine on central dopamine receptors in comparison to apomorphine, (+)-amphetamine and L-DOPA.

Authors:  A M Johnson; D M Loew; J M Vigouret
Journal:  Br J Pharmacol       Date:  1976-01       Impact factor: 8.739

3.  Suppression of puerperal lactation with an ergot alkaloid: a double-blind study.

Authors:  L Varga; P M Lutterbeck; J S Pryor; R Wenner; H Erb
Journal:  Br Med J       Date:  1972-06-24

4.  Properties of a prolactin receptor from the rabbit mammary gland.

Authors:  R P Shiu; H G Friesen
Journal:  Biochem J       Date:  1974-05       Impact factor: 3.857

5.  Effect of 2-Br- -ergokryptine (CB 154) on lactation in the bitch.

Authors:  P Mayer; E Schütze
Journal:  Experientia       Date:  1973-04-15

6.  Antagonism of 2-br- -ergokryptine-methanesulfonate (CB 154) to certain endocrine actions of centrally active drugs.

Authors:  E Flückiger; P M Lutterbeck; H R Wagner; E Billeter
Journal:  Experientia       Date:  1972-08-15

7.  Metergoline versus bromocriptine in the prevention of puerperal lactation. A double-blind clinical trial.

Authors:  F Scapin; S Buonaccorsi; G Tronconi; G Pellicciotta; A E Pontiroli
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

8.  Treatment of galactorrhea-amenorrhea syndrome with 2-Br-alpha-ergocryptin (CB 154). Clinical response and pattern of pituitary and steriod hormones before and during therapy.

Authors:  H J Künzig; W Geiger; K D Schulz; K H Lose
Journal:  Arch Gynakol       Date:  1975

9.  Galactorrhoea: successful treatment with reduction of plasma prolactin levels by brom-ergocryptine.

Authors:  G M Besser; L Parke; C R Edwards; I A Forsyth; A S McNeilly
Journal:  Br Med J       Date:  1972-09-16

10.  Dopaminergic inhibition of metoclopramide-induced aldosterone secretion in man. Dissociation of responses to dopamine and bromocriptine.

Authors:  R M Carey; M O Thorner; E M Ortt
Journal:  J Clin Invest       Date:  1980-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.